Can we increase survival in breast cancer with innovative applications of conventional drugs?

Eur J Cancer. 1994;30A(4):423-4. doi: 10.1016/0959-8049(94)90409-x.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality*
  • Doxorubicin / administration & dosage
  • Drug Administration Schedule
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Neoplasm Metastasis
  • Survival Rate

Substances

  • Doxorubicin
  • Fluorouracil